arrow
R

Riadh Gouider

razi university hospital
H指数:32
被引数:4,105

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis

在复发缓解型多发性硬化中,针对临床静息期MRI病灶的治疗升级

Brain
IF11.7
2026-07-240
OAAI
Causal effects of multiple sclerosis therapies in left-truncated registry data

多发性硬化疗法在左截断登记数据中的因果效应

2026-07-210
PRE
Migraine, headache disorders, and brain health: aligning advocacy with the UN Sustainable Development Goals

偏头痛、头痛障碍和脑健康:将倡导工作与联合国可持续发展目标对齐

2026-04-070
OAAI
Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry

迟发性对多发性硬化表型和结局的影响:多国注册研究的证据

2026-02-040
PRE
Strengthening Africa’s brain health and economic resilience

加强非洲的脑健康和经济韧性

2025-08-070
OA
Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data

基于真实世界常规临床数据的个性化联邦学习在预测多发性硬化致残进展中的应用

2025-07-240
OAAI
Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024)

四年之后:MSBase妊娠、新生儿结局及女性健康登记册(2020–2024)中报告的妊娠与分娩结局

2025-07-070
PRE
Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies
2024-11-012
OAAI
Safety and effectiveness of disease-modifying therapies after switching from natalizumab
2024-07-260
PRE
Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis A Registry-Based Study
2024-04-094
OAAI
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study

常规CSF参数可作为多发性硬化症病程的预测指标: 一项MSBase队列研究

2024-04-030
OA